Summary
- Current Price
- As of today, AVLN price is $35.46, up +2.60% on
- Current Price All-Time High
- AVLN price is currently -0.89% below its historical high of $35.78 set on
- Market Cap
- AVLN current market cap is $2B
- Revenue
- AVLN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AVLN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Avalyn Pharma Inc. |
| Ticker | NASDAQ: AVLN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | avalynpharma.com |
| Employees | 50 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $35.46 | |
| Price, 1D Change | +2.60% | |
| $2B | ||
| - | ||
| - | ||
| -0.12 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.92 | ||
| EPS, 1Y Change | -71.29% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.92 | ||
| EPS Estimate | -$1.94 | N/A |
| EPS Est. Change | -0.94% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $35.46 | |
| Price Target | $52.50 | - |
| Price Tgt. Change | +48.05% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.12 | - | |
| - | -$1.92 | - | |
| -$1.94 | N/A | -0.94% | |
| -$1.90 | N/A | +1.14% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $35.46 | |
| $29.08 | ||
| $29.31 | ||
| - | ||
| $29.61 | ||
| $1.36 | ||
| -0.12 | ||
| $2.04 | ||
| 71.08 | ||
| 43.85% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.92 | ||
| -$42.00K | ||
| - | ||
| -$91.29M | ||
| - | ||
| -$85.20M | ||
| - | ||
| -$91.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 10.19 | ||
| 10.19 | ||
| - | ||
| - | ||
| 58.11 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| -5.95 | ||
| -52.62 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$238.66M | ||
| $138.36M | ||
| $148.88M | ||
| $143.56M | ||
| $15.32M | ||
| $14.09M | ||
| $1.67M | ||
| $444.00K | ||
| $3.76M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $85.20M | ||
| $91.25M | ||
| $42.00K | ||
| $14.68M | ||
| $42.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$81.48M | ||
| $10.06M | ||
| $99.79M | ||
| $344.00K | ||
| -$81.83M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Morgan Stanley | ||
| Guggenheim | ||
| Evercore ISI Group |
Analyst sentiment
Institutional ownership
Screeners with AVLN
FAQ
- What is the ticker symbol for Avalyn Pharma Inc.?
- The ticker symbol for Avalyn Pharma Inc. is NASDAQ:AVLN
- Does Avalyn Pharma Inc. pay dividends?
- No, Avalyn Pharma Inc. does not pay dividends
- What sector is Avalyn Pharma Inc. in?
- Avalyn Pharma Inc. is in the Healthcare sector
- What industry is Avalyn Pharma Inc. in?
- Avalyn Pharma Inc. is in the Biotechnology industry
- What country is Avalyn Pharma Inc. based in?
- Avalyn Pharma Inc. is headquartered in United States
- When did Avalyn Pharma Inc. go public?
- Avalyn Pharma Inc. initial public offering (IPO) was on April 30, 2026
- Is Avalyn Pharma Inc. in the S&P 500?
- No, Avalyn Pharma Inc. is not included in the S&P 500 index
- Is Avalyn Pharma Inc. in the NASDAQ 100?
- No, Avalyn Pharma Inc. is not included in the NASDAQ 100 index
- Is Avalyn Pharma Inc. in the Dow Jones?
- No, Avalyn Pharma Inc. is not included in the Dow Jones index
- When was Avalyn Pharma Inc. last earnings report?
- Avalyn Pharma Inc.'s most recent earnings report was on June 3, 2026
- When does Avalyn Pharma Inc. report earnings?
- The next expected earnings date for Avalyn Pharma Inc. is August 14, 2026
Data Sources & References
- AVLN Official Website www.avalynpharma.com
- AVLN Profile on Yahoo Finance finance.yahoo.com/quote/AVLN
- AVLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avln